Navigation
Marktaussichten Aktienscreener Dividendenkalender Veranstaltungskalender Bewertung der Aktien Marktnachrichten
Kostenlos ausprobieren

Eton Pharmaceuticals

NASDAQ ETON
$3.62 -0.03 -0.83%
Today share price
Vereinigte Staaten von Amerika
Sector: Healthcare Industry: Pharmaceuticals
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Показатель: 36 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

93.26M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
77.31M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
1.22
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
25.76M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-17.35 %

Upcoming events Eton Pharmaceuticals

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart Eton Pharmaceuticals

Stock analysis Eton Pharmaceuticals

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.
102.15 8.71
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.
6.03 24.46
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.
52.13 4.36
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.
-10.76 0.50
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.
5.89 9.54

Price change Eton Pharmaceuticals per year

4.03$ 10.30$
Min Max

Summary analysis Eton Pharmaceuticals

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Eton Pharmaceuticals

Revenue and net income Eton Pharmaceuticals

All parameters

Stock news Eton Pharmaceuticals

All news
11 April 2022 в 15:10

Eton Pharmaceuticals Gets FDA Approval for Cysteine Hydrochloride Injection

11 April 2022 в 15:10

Eton Pharmaceuticals Gets FDA Approval for Cysteine Hydrochloride Injection

About company Eton Pharmaceuticals

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Alkindi Sprinkle, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; and Alaway Preservative Free, a preservative-free ophthalmic product to treat allergic conjunctivitis. It also develops ET-105, a lamotrigine for oral suspension; DS-300, a cysteine injection; DS-100, a dehydrated alcohol injection; ET-104, a zonisamide oral suspension; ET-101, a topiramate oral suspension; and ET-203, an ephedrine ready-to-use injection. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
Address:
21925 West Field Parkway, Deer Park, IL, United States, 60010-7208
Company name: Eton Pharmaceuticals
Issuer ticker: ETON
ISIN: US29772L1089
Country: Vereinigte Staaten von Amerika
Exchange: NASDAQ
Currency: $
IPO date: 2018-11-13
Sector: Healthcare
Industry: Pharmaceuticals
Site: https://www.etonpharma.com

On which stock exchange are Eton Pharmaceuticals (ETON) stocks traded?

Eton Pharmaceuticals (ETON) stocks are traded on NASDAQ.

What is the ticker of Eton Pharmaceuticals stocks (ETON)?

The stock ticker of Eton Pharmaceuticals’s stocks or in other words, the code is ETON. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Eton Pharmaceuticals (ETON) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Eton Pharmaceuticals (ETON) belongs to the «Healthcare» sector and the «Pharmaceuticals» industry.

In what currency are Eton Pharmaceuticals (ETON) stocks traded?

Eton Pharmaceuticals (ETON) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Eton Pharmaceuticals (ETON) stocks today?

The current price of Eton Pharmaceuticals stocks on 18.05.2024 is 3.62 dollars. per share.

What is the dynamics of Eton Pharmaceuticals (ETON) stocks from the beginning of the year?

Eton Pharmaceuticals (ETON) quotes have increased by -21.13% from the beginning of the year up to 3.62 dollars. per 1 stocks.

How much did Eton Pharmaceuticals (ETON) stocks increase in мае 2024?

This month Eton Pharmaceuticals (ETON) quotes have increased by -1.63% to 3.62 dollars. per share.

How much are Eton Pharmaceuticals (ETON) stocks worth?

Today, on October, 18.05.2024 Eton Pharmaceuticals’s (ETON) stocks cost 3.62 dollars..

What is the market capitalization of Eton Pharmaceuticals (ETON)?

Capitalization is the market value of Eton Pharmaceuticals (ETON) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 18.05.2024, the market capitalization of Eton Pharmaceuticals (ETON) is estimated at about 93262060 dollars.